谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Safety and Immunogenicity of the Chlamydia Vaccine Candidate CTH522 Adjuvanted with CAF01 Liposomes or Aluminium Hydroxide: a First-in-human, Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial.

Sonya Abraham,Helene B. Juel,Peter Bang,Hannah M. Cheeseman, Rebecca B. Dohn,Tom Cole,Max P. Kristiansen,Karen S. Korsholm,David Lewis,Anja W. Olsen,Leon R. McFarlane,Suzanne Day, Sara Knudsen, Kjersti Moen,Morten Ruhwald,Ingrid Kromann,Peter Andersen,Robin J. Shattock,Frank Follmann

The Lancet Infectious Diseases（2019）

引用 118|浏览53
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要